Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Transcenta Received IND Clearance from US FDA for Initiating Phase I Clinical Trial for its Bi-functional Anti-PD-L1/TGF-β Antibody TST005
2021-04-20 20:54
Biovaxys And The World Ovarian Cancer Coalition Join Forces For May 8th, World Ovarian Cancer Day
2021-04-20 20:00
AACR 2021-ImmVira presents the preclinical study results of MVR-T3011 via intravenous administration
2021-04-20 08:30
Abbott's Fast, Reliable and Convenient COVID-19 Tests Help the Philippines Fight Infection Surge
2021-04-20 06:00
Himalaya Therapeutics Announces Appointment of Nicholas Desjardins as Chief Financial Officer
2021-04-20 01:42
China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port
2021-04-19 20:30
CNPharm has succeeded in maintaining IC100 for 24 hours with one injection
2021-04-19 20:15
Kazia Licenses Global Rights to EVT801, a Novel, First-in-Class, Clinic-Ready, VEGFR3 Inhibitor, from Evotec SE
2021-04-19 17:54
Transcenta Announced Successful First Patient Dosed in Phase I Clinical Study of TST001 Combined with CAPOX for the Treatment of Patients with First-line Locally Advanced Unresectable or Metastatic Gastric Cancer
2021-04-19 08:00
Qilu Pharmaceutical and Peptron Sign License Agreement for anti-MUC1 ADC
2021-04-16 20:00
Kintor Pharmaceuticals Announced Successful Dosing of the First Batch of Patients for Acne Vulgaris Phase I/II Clinical Trial of Pyrilutamide
2021-04-16 18:29
GT Apeiron Therapeutics Strengthens Advisory Board
2021-04-16 09:00
Kintor Pharmaceutical Announces AR-PROTAC (GT20029) Approved for Acne and Androgenic Alopecia Clinical Trials in China
2021-04-15 18:20
Juniper Biologics Announces the Appointment of Raman Singh as Chief Executive
2021-04-15 16:30
New clinical study shows JOYSBIO COVID-19 neutralizing antibody rapid test nearly 98% accurate in verifying antibodies after vaccination
2021-04-15 14:20
Seegene's Italy subsidiary secures public procurement for 7.15 million COVID-19 diagnostic tests, the largest tender in history
2021-04-15 14:19
Everest Medicines Appoints Jennifer Yang as Chief Scientific Officer
2021-04-15 08:36
Everest Medicines Announces that the US FDA has Granted Licensing Partner Gilead Sciences, Inc. Accelerated Approval of Trodelvy® for the Treatment of Metastatic Urothelial Cancer
2021-04-14 21:33
Gannex Announces the First Cohort Dosed in a U.S. Clinical Study with THR-β Agonist ASC41
2021-04-14 20:00
BioVaxys Announces Final Clinical trial results of HPV product from EU partner ProCare Health Iberia published by American Society for Colposcopy and Cervical Pathology
2021-04-14 20:00
1
248
249
250
251
252
412